全球藥物安全檢測市場規模、佔有率、成長分析（按類型、應用、最終用戶）- 產業預測，2024-2031 年

2022年全球藥物安全檢測市場規模為90.7億美元，從2023年的97.5億美元成長到2031年的173.9億美元，預計在預測期間（2024-2031年）將以年複合成長率7.5%成長。

由於對病人安全的日益關注、監管標準的收緊和製藥領域的擴大，全球藥物安全檢測市場正在顯著成長。此市場分析提供了對全球藥物安全檢測市場的主要趨勢、促進因素/挑戰和區域差異的見解。推動藥物安全檢測市場擴張的關鍵因素是對藥物安全性監測的需求不斷增加，特別是面對藥物複雜性的增加和新療法的出現。世界各地的監管機構正在執行嚴格的指導方針，並鼓勵製藥公司採用強力的藥物安全檢測通訊協定，從而促進市場成長。此外，慢性病的流行和藥物消費的快速增加強調了藥物安全檢測的重要性。副作用和用藥錯誤對病人健康、醫療保健支出和法律義務的影響強調了有效藥物安全檢測系統的必要性。因此，醫療保健提供者和監管機構強調需要強大的藥物安全檢測機制來快速識別和解決不利事件，從而提高病患安全和整體醫療保健結果。

目錄

執行摘要

• 市場概況
• 繁榮與衰落

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模估算
• 市場危機與限制

母市場分析

• 市場概況
• 市場規模
• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務

主要市場考察

• 技術分析
• 價格分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 智慧財產權分析
• 貿易分析
• Start-Ups分析
• 原料分析
• 創新矩陣
• 研發線產品分析
• 總體經濟指標
• 主要投資分析
• 關鍵成功因素
• 競爭程度

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 監管環境
• 波特的分析
• 對未來中斷的特殊考慮

全球藥物安全檢測市場：按類型

• 市場概況
• 內部藥物警戒與合約外包藥物警戒

全球藥物安全檢測市場：依應用分類

• 市場概況
• 自願報告
• 中央監控程序
• 上市後監測
• 危機管理
• 訊號檢測與評估
• 效益-風險評估與安全資料庫管理

全球藥物安全檢測市場：依最終使用者分類

• 市場概況
• 製藥公司
• 合約研究組織 (CRO) 和其他醫療保健提供者

全球藥物安全檢測市場規模：按地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2021年）
• 主要市場參與者所採取的策略
• 關鍵成功策略
• 近期市集活動
• 主要企業市場佔有率（2021年）

主要企業簡介

• QuintilesIMS（美國）
• 埃森哲（愛爾蘭）
• 高知特（美國）
• IBM公司（美國）
• 甲骨文公司（美國）
• PAREXEL國際公司（美國）
• ArisGlobal（美國）
• ICON plc（愛爾蘭）
• IQVIA（美國）
• PRA 健康科學（美國）
• Wipro 有限公司（印度）
• 凱捷公司（法國）
• 塔塔諮詢服務有限公司（印度）
• BioClinica, Inc.（美國）
• Sciformix 公司（美國）
• 科文斯公司（美國）
• Bioclinica（美國）
• HCL 技術有限公司（印度）
• Foresight Group International AG（瑞士）
• TAKE 解決方案有限公司（印度）

Global Pharmacovigilance Market size was valued at USD 9.07 billion in 2022 and is poised to grow from USD 9.75 billion in 2023 to USD 17.39 billion by 2031, growing at a CAGR of 7.5% in the forecast period (2024-2031).

The global pharmacovigilance market has witnessed substantial growth due to heightened attention to patient safety, escalating regulatory standards, and the expanding pharmaceutical sector. This market analysis offers insights into key trends, drivers, challenges, and regional variations within the global pharmacovigilance market. A pivotal factor propelling its expansion is the escalating demand for monitoring drug safety, particularly in the face of burgeoning drug complexity and the advent of novel therapeutics. Regulatory bodies worldwide are enforcing rigorous guidelines, compelling pharmaceutical firms to adopt robust pharmacovigilance protocols, thus propelling market growth. Moreover, the surge in chronic disease prevalence and medication consumption underscores the criticality of pharmacovigilance. The ramifications of adverse drug reactions and medication errors on patient well-being, healthcare expenditure, and legal obligations highlight the imperative for effective pharmacovigilance systems. Consequently, healthcare providers and regulatory entities stress the necessity for robust pharmacovigilance mechanisms to promptly identify and address adverse events, thereby augmenting patient safety and overall healthcare outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the global pharmacovigilance market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmacovigilance Market Segmental Analysis

The global pharmacovigilance market is segmented on the basis of type, application, end-user and region. Based on type, the market can be segmented into In-House Pharmacovigilance and Contract Outsourcing Pharmacovigilance. Based on application, the market is segmented into Spontaneous Reporting, Intensive Monitoring Programs, Post-Marketing Surveillance, Risk Management, Signal Detection and Evaluation, Benefit-Risk Assessment and Safety Database Management. By End - user it can be segmented into Pharmaceutical Companies, Contract Research Organizations (CROs) and Other Healthcare Providers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Pharmacovigilance Market

The upward trend in adverse drug reactions (ADRs) globally propels the pharmacovigilance market forward, spurred by the expanding use of pharmaceuticals which heightens the likelihood of encountering unforeseen adverse events. Pharmacovigilance assumes a pivotal role in monitoring and documenting ADRs, enabling prompt detection, risk assessment, and implementation of necessary interventions to ensure patient safety. The increasing incidence of ADRs underscores the necessity for pharmacovigilance services and solutions, thus propelling the growth of the market.

Restraints in the Global Pharmacovigilance Market

One of the challenges faced by the global pharmacovigilance market stems from the insufficient awareness and infrastructure in developing regions, which struggle to establish and execute robust pharmacovigilance systems. The lack of understanding regarding the importance of pharmacovigilance, coupled with inadequate regulatory structures and resource limitations, obstructs the uptake of efficient pharmacovigilance protocols. Additionally, the dearth of infrastructure, shortage of trained personnel, and inadequate data management systems present further obstacles to the expansion of the pharmacovigilance market in these areas.

Market Trends of the Global Pharmacovigilance Market

In recent years, there has been a notable surge in drug consumption and development, which, when coupled with prolonged use and widespread usage, poses potential risks of adverse effects for patients. Consequently, the increasing demand for medical oversight from regulatory bodies acts as a catalyst for the expansion of the pharmacovigilance market. Furthermore, the pharmaceutical sector has increasingly embraced pharmacovigilance services, driving growth in this sector. For instance, the collaboration between IQVIA and NRx Pharmaceuticals in September 2021 aimed to offer pharmacovigilance services and medical information, ensuring preparedness for potential regulatory actions. These industry trends underscore the growing acknowledgment of the pivotal role pharmacovigilance plays in ensuring drug safety and regulatory adherence.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global PharmaCovigilances Market by Type

• Market Overview
• In-House Pharmacovigilance and Contract Outsourcing Pharmacovigilance

Global PharmaCovigilances Market by Application

• Market Overview
• Spontaneous Reporting
• Intensive Monitoring Programs
• Post-Marketing Surveillance
• Risk Management
• Signal Detection and Evaluation
• Benefit-Risk Assessment and Safety Database Management.

Global PharmaCovigilances Market by End-User

• Market Overview
• Pharmaceutical Companies
• Contract Research Organizations (CROs) and Other Healthcare Providers.

Global PharmaCovigilances Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• QuintilesIMS (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accenture (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cognizant (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PAREXEL International Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ArisGlobal (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PRA Health Sciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wipro Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Capgemini SE (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tata Consultancy Services Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioClinica, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sciformix Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covance Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioclinica (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HCL Technologies Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Foresight Group International AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TAKE Solutions Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments